Effects of Instrument Assisted Soft Tissue Mobilization on Delayed Onset Muscle Soreness
NCT ID: NCT05531851
Last Updated: 2022-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2022-08-29
2022-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Instrument Assisted Soft Tissue Mobilization in Female Patients With Myofascial Pain Syndrome
NCT05297656
Comparison of Two Different Fascial Treatments
NCT06715969
Different Exercise Trainings in Patients With Chronic Pain From Exercise Adherence, Clinical and Economic Perspectives
NCT05851495
Changes in Thoracolumbar Fascia Stiffness and Pain Parameters in Young Patients With Chronic Low Back Pain
NCT06537219
The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders
NCT07317570
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experiment group.
İnstrument-assisted soft tissue mobilization will be applied after the delayed onset muscle soreness induction protocol
Instrument Assisted Soft Tissue Mobilization
For IASTM treatment, IASTM soft tissue mobilization blade to apply the treatment used. It is a stainless steel shaped metal tool with beveled edges. The researcher, with a 30° angled tool, at a speed of 120 BPM, in the direction of the fibers of the m.biceps brachii muscle.
He applied it with a light pressure by intervening with his weight. Researcher during treatment used a metronome to ensure consistent speed and adjusted the instrument angle before each subject's treatment.
calibrated with a protractor. The application took 8 minutes and the instrument was comfortable on the skin.
Control Group
Delayed onset muscle soreness generation protocol will be applied
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Instrument Assisted Soft Tissue Mobilization
For IASTM treatment, IASTM soft tissue mobilization blade to apply the treatment used. It is a stainless steel shaped metal tool with beveled edges. The researcher, with a 30° angled tool, at a speed of 120 BPM, in the direction of the fibers of the m.biceps brachii muscle.
He applied it with a light pressure by intervening with his weight. Researcher during treatment used a metronome to ensure consistent speed and adjusted the instrument angle before each subject's treatment.
calibrated with a protractor. The application took 8 minutes and the instrument was comfortable on the skin.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No fear of needles,
3. Having read and understood the Informed Voluntary Consent Form and agreeing to participate in the study.
Exclusion Criteria
2. Having any cardiovascular, pulmonary and metabolic disease,
3. Any musculoskeletal injury in the last 6 months,
4. Having a history of pain and surgery in the upper extremity,
5. Participating in upper extremity weight training in the last 6 months,
6. Exercise, caffeine and alcohol consumption, and drug use up to 12 hours before the study were determined as
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harran University
OTHER
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İSMAİL PALALI
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İsmail Palalı, PhD (c)
Role: PRINCIPAL_INVESTIGATOR
Harran University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harran University
Sanliurfa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SaglikBilimleriU-63
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.